Insight Molecular Diagnostics Inc. (IMDX)

Profile

Full Name

Insight Molecular Diagnostics Inc.

Ticker

NASDAQ: IMDX

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

December 30, 2015

Indexes

Not included

Website

http://imdxinc.com

Employees

46

Key Details

Price

$2.88(-2.53%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.88M(+25.15% YoY)

Annual EPS

-$4.66(-24.27% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.88
    IMDX price is $2.88

    30-Day Relative Volume

    0.45
    IMDX 30-day relative volume is 0.45

    Price Performance

    Price Most recent change

    -2.53%
    IMDX price was down -2.53% on Jul 25, 2025

    Price YTD change

    +21.22%
    IMDX price is up +21.22% since January 1st

    Price 1-year change

    -14.14%
    IMDX price is down -14.14% year-on-year

    Price 3-year change

    -82.97%
    IMDX price is down -82.97% over the past 3 years

    Price Range

    Price All-time high

    $204.80
    IMDX price is currently -98.59% below its historical high of $204.80

    Price 3-year low

    $1.92
    IMDX price is currently +50.10% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $82.51M
    IMDX market capitalization is $82.51 million

    Market cap 3-year change

    -17.87%
    IMDX market capitalization is down -17.87% over the past 3 years

    Market cap All-time high

    $569.45M
    IMDX market capitalization is currently -85.51% below its historical high of $569.45 million

    Market cap sector rank

    39.57%
    IMDX market capitalization is higher than 39.57% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +113.93%
    IMDX shares outstanding is up +113.93% year-on-year

    Shares Outstanding 3-Year Change

    +382.24%
    IMDX shares outstanding is up +382.24% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.09
    IMDX beta is 0.09

    200-day SMA

    $2.82
    IMDX price is currently +2.30% above its 200-day simple moving average

    50-day SMA

    $3.03
    IMDX price is currently -4.74% below its 50-day simple moving average

    RSI

    47.05
    IMDX 14-day relative strength index is 47.05

    Volume

    0.45
    IMDX 30-day relative volume is 0.45

    ATR

    $0.24
    IMDX average true range is $0.24

    10-day Historical Volatility

    60.03%
    IMDX 10-day historical volatility is 60.03%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.88M
    IMDX annual revenue is $1.88 million

    Revenue Analysts estimate

    $3.04M
    IMDX annual revenue is currently -38.21% lower than the consensus analysts' forecast

    Revenue 1-year change

    +25.15%
    IMDX annual revenue is up +25.15% year-on-year

    Revenue Sector rank

    14.74%
    IMDX annual revenue is higher than 14.74% of companies in Healthcare sector

    EPS

    EPS

    -$4.66
    IMDX annual earnings per share is -$4.66

    EPS Analysts estimate

    -$0.99
    IMDX annual earnings per share is currently +370.71% higher than the consensus analysts' forecast

    EPS 1-year change

    -24.27%
    IMDX annual earnings per share is down -24.27% year-on-year

    EPS Sector rank

    21.49%
    IMDX annual earnings per share is higher than 21.49% of companies in Healthcare sector

    Profit

    Gross profit

    $740.00K
    IMDX annual gross profit is $740.00 thousand

    Gross margin

    39.34%
    IMDX annual gross profit margin is 39.34%

    Operating profit

    -$23.25M
    IMDX annual operating income is -$23.25 million

    Operating margin

    -1235.89%
    IMDX annual operating profit margin is -1235.89%

    Net income

    -$60.66M
    IMDX annual net profit is -$60.66 million

    Net margin

    -3225.04%
    IMDX annual net profit margin is -3225.04%

    Expenses

    Total expenses

    $25.13M
    IMDX annual total expenses is $25.13 million

    Operating expenses

    $23.99M
    IMDX annual total operating expenses is $23.99 million

    Cost of goods sold

    $1.14M
    IMDX annual cost of goods sold is $1.14 million

    Selling, general & administrative expenses

    $13.79M
    IMDX annual SGA is $13.79 million

    Depreciation and amortization

    $1.56M
    IMDX annual depreciation & amortization is $1.56 million

    Interest expense

    $84.00K
    IMDX annual interest expense is $84.00 thousand

    Income tax

    -
    IMDX annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$60.58M
    IMDX annual earnings before interest & taxes is -$60.58 million

    EBITDA

    -$59.02M
    IMDX annual EBITDA is -$59.02 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $35.08M
    IMDX annual total assets is $35.08 million

    Non current assets

    $23.32M
    IMDX annual long term assets is $23.32 million

    Current assets

    $11.76M
    IMDX annual total current assets is $11.76 million

    Cash and cash equivalents

    $8.64M
    IMDX annual cash & cash equivalents is $8.64 million

    Accounts receivable

    $1.61M
    IMDX annual accounts receivable is $1.61 million

    Inventory

    $410.00K
    IMDX annual inventory is $410.00 thousand

    Liabilities

    Total liabilities

    $47.35M
    IMDX annual total liabilities is $47.35 million

    Long term liabilities

    $40.08M
    IMDX annual total long term liabilities is $40.08 million

    Current liabilities

    $7.28M
    IMDX annual total current liabilities is $7.28 million

    Accounts payable

    $2.28M
    IMDX annual accounts payable is $2.28 million

    Debt

    Total debt

    $3.66M
    IMDX annual total debt is $3.66 million

    Total debt 1-year change

    +27.71%
    IMDX annual total debt is up +27.71% year-on-year

    Long term debt

    $2.37M
    IMDX annual long term debt is $2.37 million

    Short term debt

    $1.29M
    IMDX annual short term debt is $1.29 million

    Equity & Capital

    Shareholders equity

    -$12.27M
    IMDX annual stockholders equity is -$12.27 million

    Book value

    -$12.27M
    IMDX annual book value is -$12.27 million

    Retained earnings

    -$350.54M
    IMDX annual retained earnings is -$350.54 million

    Working capital

    $4.48M
    IMDX annual working capital is $4.48 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$20.71M
    IMDX annual cash flow from operations is -$20.71 million

    Cash from operations 1-year change

    +11.2%
    IMDX annual cash flow from operations is up +11.2% year-on-year

    Cash from investing

    -$512.00K
    IMDX annual cash flow from investing activities is -$512.00 thousand

    Cash from investing 1-year change

    +45.06%
    IMDX annual cash flow from investing activities is up +45.06% year-on-year

    Cash from financing

    $20.43M
    IMDX annual cash flow from financing activities is $20.43 million

    Cash from financing 1-year change

    +67.64%
    IMDX annual cash flow from financing activities is up +67.64% year-on-year

    CAPEX

    CAPEX

    $516.00K
    IMDX annual capital expenditures is $516.00 thousand

    CAPEX 1-year change

    +83.63%
    IMDX annual capital expenditures is up +83.63% year-on-year

    Free Cash Flow

    Free cash flow

    -$21.23M
    IMDX annual free cash flow is -$21.23 million

    Free cash flow 1-year change

    +10.07%
    IMDX annual free cash flow is up +10.07% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    39.34%
    IMDX annual gross profit margin is 39.34%

    Operating margin

    -1235.89%
    IMDX annual operating profit margin is -1235.89%

    Net margin

    -3225.04%
    IMDX annual net profit margin is -3225.04%

    ROA & ROE

    ROA

    -110.32%
    IMDX annual return on assets is -110.32%

    ROE

    -1480.67%
    IMDX annual return on equity is -1480.67%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    IMDX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    IMDX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    8.07
    IMDX price to book ratio is 8.07

    PB ratio Sector rank

    86.27%
    IMDX price to book ratio is higher than 86.27% of companies in Healthcare sector

    PS Ratio

    PS ratio

    21.47
    IMDX price to sales ratio is 21.47

    PS ratio Sector rank

    85.07%
    IMDX price to sales ratio is higher than 85.07% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $54.96M
    IMDX enterprise value is $54.96 million

    Enterprise value Sector rank

    36.95%
    IMDX enterprise value is higher than 36.95% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.97
    IMDX EV/EBITDA is -0.97

    EV/EBITDA Sector rank

    50.79%
    IMDX EV/EBITDA is higher than 50.79% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.62
    IMDX annual current ratio is 1.62

    Quick ratio

    1.56
    IMDX annual quick ratio is 1.56

    Leverage

    Debt to equity

    0.00
    IMDX annual debt to equity ratio is 0.00

    Interest coverage ratio

    -721.18
    IMDX annual interest coverage ratio is -721.18

    Risk & Stability

    Piotroski F-Score

    5
    IMDX piotroski f-score is 5

    Altman Z-Score

    -18.44
    IMDX altman z-score is -18.44

    Analyst ratings

    Recent major analysts updates

    May 21, 25 Lake Street
    Buy
    May 13, 25 Needham
    Buy
    Apr 8, 25 Needham
    Buy
    Mar 28, 25 Lake Street
    Buy
    Mar 26, 25 Stephens & Co.
    Equal-Weight
    Mar 25, 25 Stephens & Co.
    Equal-Weight
    Mar 25, 25 Needham
    Buy

    Institutional Ownership

    Screeners with IMDX included

    Growing Shares Outstanding
    US stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks YTD
    Ex Dividend dates calendar
    Small cap stocks
    • What is the ticker symbol for Insight Molecular Diagnostics Inc.?
    • Does Insight Molecular Diagnostics Inc. pay dividends?
    • What sector is Insight Molecular Diagnostics Inc. in?
    • What industry is Insight Molecular Diagnostics Inc. in?
    • What country is Insight Molecular Diagnostics Inc. based in?
    • When did Insight Molecular Diagnostics Inc. go public?
    • Is Insight Molecular Diagnostics Inc. in the S&P 500?
    • Is Insight Molecular Diagnostics Inc. in the NASDAQ 100?
    • Is Insight Molecular Diagnostics Inc. in the Dow Jones?
    • When was Insight Molecular Diagnostics Inc.'s last earnings report?
    • When does Insight Molecular Diagnostics Inc. report earnings?

    What is the ticker symbol for Insight Molecular Diagnostics Inc.?

    The ticker symbol for Insight Molecular Diagnostics Inc. is NASDAQ:IMDX

    Does Insight Molecular Diagnostics Inc. pay dividends?

    No, Insight Molecular Diagnostics Inc. does not pay dividends

    What sector is Insight Molecular Diagnostics Inc. in?

    Insight Molecular Diagnostics Inc. is in the Healthcare sector

    What industry is Insight Molecular Diagnostics Inc. in?

    Insight Molecular Diagnostics Inc. is in the Diagnostics & Research industry

    What country is Insight Molecular Diagnostics Inc. based in?

    Insight Molecular Diagnostics Inc. is headquartered in United States

    When did Insight Molecular Diagnostics Inc. go public?

    Insight Molecular Diagnostics Inc.'s initial public offering (IPO) was on December 30, 2015

    Is Insight Molecular Diagnostics Inc. in the S&P 500?

    No, Insight Molecular Diagnostics Inc. is not included in the S&P 500 index

    Is Insight Molecular Diagnostics Inc. in the NASDAQ 100?

    No, Insight Molecular Diagnostics Inc. is not included in the NASDAQ 100 index

    Is Insight Molecular Diagnostics Inc. in the Dow Jones?

    No, Insight Molecular Diagnostics Inc. is not included in the Dow Jones index

    When was Insight Molecular Diagnostics Inc.'s last earnings report?

    Insight Molecular Diagnostics Inc.'s most recent earnings report was on May 12, 2025

    When does Insight Molecular Diagnostics Inc. report earnings?

    The next expected earnings date for Insight Molecular Diagnostics Inc. is August 8, 2025
    On this page